-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2023-NHQDR-appendixes-ACDE.pdf
January 01, 2023 - 2023 National Healthcare Quality and Disparities Report Appendixes
2023
National Healthcare
Quality and Disparities
Report Appendixes
This document is in the public domain and may be used and reprinted without permission.
Citation of the source is appreciated.
Suggested citation: 2023 National Healthcare Quali…
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2022qdr-appendix-combined.pdf
October 25, 2022 - 2022 National Healthcare Quality and Disparities Report Appendixes
2022 National Healthcare Quality and
Disparities Report
Appendixes
U.S. DEPARTMENT OF
HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
5600 Fishers Lane
Rockville, MD 20857
www.ahrq.gov
AHRQ Publication No. 22(23)-0030
…
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2023-NHQDR-appendixes-ACDE-rev.pdf
January 01, 2023 - 2023 National Healthcare Quality and Disparities Report Appendixes
2023
National Healthcare
Quality and Disparities
Report Appendixes
This document is in the public domain and may be used and reprinted without permission.
Citation of the source is appreciated.
Suggested citation: 2023 National Healthcare Quali…
-
www.ahrq.gov/sites/default/files/publications/files/confidreportguide_1.pdf
March 01, 2016 - Confidential Physician Feedback Reports: Designing for Optimal Impact on Performance
Confidential Physician
Feedback Reports:
Designing for Optimal
Impact on Performance
Agency for Healthcare Research and Quality
Advancing Excellence in Health Care www.ahrq.gov
This guide is a practical resource designe…
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/making-healthcare-safer/mhs3/anticoagulants-1.pdf
March 01, 2020 - Chapter-7 - Harm Due to Anticoagulants
Harms Due to Anticoagulants 7-1
7. Harms Due to Anticoagulants
Authors: Sarah J. Shoemaker-Hunt, Ph.D., Pharm.D., and Brandy Wyant, M.P.H.
Introduction
Anticoagulants are a critical therapy in the prevention and treatment of various types of
thromboembolic disorders. Key in…
-
www.ahrq.gov/research/findings/nhqrdr/2014chartbooks/hispanichealth/hisph-slides.html
March 01, 2020 - This marked the beginning of a new era in addressing minority health issues, beginning with the creation
-
www.ahrq.gov/sites/default/files/wysiwyg/data/hfmd-methodology-report.pdf
August 02, 2024 - The discussion below illustrates the detailed
findings and summarizes some observations and issues for
-
www.ahrq.gov/sites/default/files/publications/files/confidreportguide_0.pdf
March 01, 2016 - Confidential Physician Feedback Reports: Designing for Optimal Impact on Performance
Confidential Physician
Feedback Reports:
Designing for Optimal
Impact on Performance
Agency for Healthcare Research and Quality
Advancing Excellence in Health Care www.ahrq.gov
This guide is a practical resource designe…
-
www.ahrq.gov/news/newsroom/ahrq-stats.html
July 01, 2025 - AHRQ Stats
New data nuggets from AHRQ News Now posted weekly to highlight AHRQ statistical reports on health care trends. Adverse Drug Events Involving Hypoglycemic Agents In 2021, 7.5 percent of Hispanic patients, 6.6 percent of Black patients, 6.2 percent of patients with an “other” or unknown race, and 4.0…
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/quality-resources/apcd/apcd-inventory.xlsx
October 01, 2015 - Sheet1
Measure Characteristics Overall Measure Inventory Details Deep Dive Measure Inventory Details
Condition of Focus Measure Condition Subcategory Measure Type (Cost, Quality, or Utilization) Quality Category (Process, Outcomes, Structure, Not Applicable) Measure Name or Paper Name (From Lit Review) …
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/duration/chipra-156-section-6b.pdf
January 01, 2013 - Section 6.B, Validation Studies
SECTION VI.
SCIENTIFIC SOUNDNESS OF THE MEASURE
VI.B. Validity
VI.B.1 Construct Validity
To examine construct validity, we performed comparative analyses between our metri…